QuidelOrtho Receives FDA Approval for STD Assay - San Diego Business Journal

QuidelOrtho secures FDA clearance for Vitros Syphilis Assay, aiming to address the syphilis epidemic in the U.S. under new CEO Brian Blaser. The company plans to enhance production, invest in new tech, and expand markets, with a focus on adding new tests like syphilis to its portfolio.